Partner With Us

Cell and gene therapies are transforming the way we care for patients. We believe that improving the current technologies and processes is necessary to speed up discoveries of new therapies for patient treatment. Even though non-viral cell transfection is safer than viral transduction, resulting low transfection efficiency and high cytotoxicity are a major bottleneck to your scientific discovery. WaveCyte is developing a technology platform that enables high transfection efficiency and viability even in hard to transfect cells such as primary T cells and stem cells. Contact info@wavecyte.com to gain access to our pre-launch partnership programs to help accelerate your research.

Menu

Send us a message

Plymouth, MN Office

Partner With Us

Quick Links